Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05284240 · ClinicalTrials.gov registry record · NA
Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries
A NA study, sponsored by Midwest Cardiovascular Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05284240 is a NA study that has completed, run by Midwest Cardiovascular Research Foundation. The registered enrollment target is 60 participants.
The verdict
NCT05284240, a NA study, has completed, sponsored by Midwest Cardiovascular Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The Auryon Laser Atherectomy System has been cleared by the FDA to treat infrainguinal arterial disease including in-stent restenosis
Interventions
- DEVICE Auryon Laser System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-03-17 |
| Est. Completion | 2024-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05284240
The ClinicalTrials.gov registry entry for NCT05284240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Cardiovascular Research Foundation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Auryon Laser System is the first listed.
NCT05284240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05284240 about?
NCT05284240 is a clinical study titled "Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries". The Auryon Laser Atherectomy System has been cleared by the FDA to treat infrainguinal arterial disease including in-stent restenosis
What is the current status of trial NCT05284240?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-03-17. Estimated completion is 2024-09-25.
What interventions are being tested in trial NCT05284240?
The interventions under investigation include: Auryon Laser System (DEVICE).
Who is sponsoring clinical trial NCT05284240?
This trial is sponsored by Midwest Cardiovascular Research Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.